LAUREN LOWERY: Open Payments
NPI 1598492902 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,701 in 53 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,701
Food & beverage: $1,602Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $548 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $272 |
| Regeneron Healthcare Solutions, Inc. | 4 | $218 |
| ABBVIE INC. | 7 | $175 |
| Celltrion USA Inc. | 9 | $159 |
| PFIZER INC. | 5 | $107 |
| W. L. Gore & Associates, Inc. | 1 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $98 |
| Novo Nordisk Inc | 1 | $20 |
Products named: TREMFYA, XIFAXAN, VEGZELMA, RINVOQ, GORE VIATORR TIPS Endoprosthesis with Controlled Expansion, ENTYVIO, DUPIXENT, VELSIPITY.
Industry payments across CA — which companies pay providers there.
